Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation - PubMed (original) (raw)

Review

Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation

R L Ryall. World J Urol. 1997.

No abstract available

PubMed Disclaimer

Similar articles

• Inhibition of calcium oxalate crystallization by urinary macromolecules.
  Bek-Jensen H, Tiselius HG. Bek-Jensen H, et al. Urol Res. 1991;19(3):165-9. doi: 10.1007/BF00303743. Urol Res. 1991. PMID: 1887524
• Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
  Borghi L, Guerra A, Meschi T, Briganti A, Schianchi T, Allegri F, Novarini A. Borghi L, et al. Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x. Kidney Int. 1999. PMID: 10027942
• Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
  Khan SR. Khan SR. Scanning Microsc. 1995 Jun;9(2):597-614; discussion 614-6. Scanning Microsc. 1995. PMID: 8714752 Review.
• The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.
  Gohel MD, Shum DK, Li MK. Gohel MD, et al. Urol Res. 1992;20(1):13-7. doi: 10.1007/BF00294328. Urol Res. 1992. PMID: 1736481
• Crystallization in the nephron.
  Højgaard I, Tiselius HG. Højgaard I, et al. Urol Res. 1999 Dec;27(6):397-403. doi: 10.1007/s002400050127. Urol Res. 1999. PMID: 10651126 Review. No abstract available.

Cited by

• Intrinsically Disordered Osteopontin Fragment Orders During Interfacial Calcium Oxalate Mineralization.
  Lu H, Ng DYW, Lieberwirth I, Weidner T, Bonn M. Lu H, et al. Angew Chem Int Ed Engl. 2021 Aug 16;60(34):18577-18581. doi: 10.1002/anie.202105768. Epub 2021 Jul 16. Angew Chem Int Ed Engl. 2021. PMID: 34118104 Free PMC article.
• Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis.
  Wright CA, Howles S, Trudgian DC, Kessler BM, Reynard JM, Noble JG, Hamdy FC, Turney BW. Wright CA, et al. Mol Cell Proteomics. 2011 Aug;10(8):M110.005686. doi: 10.1074/mcp.M110.005686. Epub 2011 Apr 7. Mol Cell Proteomics. 2011. PMID: 21474797 Free PMC article.
• Hypocitraturia: pathophysiology and medical management.
  Zuckerman JM, Assimos DG. Zuckerman JM, et al. Rev Urol. 2009 Summer;11(3):134-44. Rev Urol. 2009. PMID: 19918339 Free PMC article.
• Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.
  Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, Neisius A, Philip J, Saita A, Shah H, Osther PJ. Jung H, et al. World J Urol. 2017 Sep;35(9):1331-1340. doi: 10.1007/s00345-017-2000-1. Epub 2017 Feb 3. World J Urol. 2017. PMID: 28160089 Review.
• Nucleation of calcium oxalate crystals on an imprinted polymer surface from pure aqueous solution and urine.
  Egan TJ, Rodgers AL, Siele T. Egan TJ, et al. J Biol Inorg Chem. 2004 Mar;9(2):195-202. doi: 10.1007/s00775-003-0517-9. Epub 2004 Jan 13. J Biol Inorg Chem. 2004. PMID: 14722741

References

1. 1. Clin Sci (Lond). 1982 Jan;62(1):17-9 - PubMed
2. 1. J Urol. 1985 Sep;134(3):503-5 - PubMed
3. 1. J Urol. 1978 Jul;120(1):6-10 - PubMed
4. 1. Br J Urol. 1995 Jun;75(6):712-9 - PubMed
5. 1. Clin Chim Acta. 1981 Nov 25;117(1):63-73 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information